Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00591617 · ClinicalTrials.gov registry record · NA

Optimizing Outcomes Using Suboxone for Opiate Dependence

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
202
Enrollment target

NCT00591617: Completed NA study, sponsored by University of California, Los Angeles.

NCT00591617 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 202 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00591617, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
202 participants
Enrollment target

Study Summary

Building on a platform of pharmacological treatment with Suboxone (buprenorphine and naloxone), participants are randomly assigned to one of four psychosocial treatment conditions.

Interventions

  • OTHER Psychosocial treatment plus Suboxone pharmacotherapy

Trial Details

FieldValue
Enrollment Target 202 participants
Start Date 2006-09
Est. Completion 2012-12
Phase NA

What the finished NCT00591617 record still lists

NCT00591617 is an interventional study that assigns participants to a tested intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 1 intervention - of which Psychosocial treatment plus Suboxone pharmacotherapy is the first listed.

NCT00591617 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00591617 about?

NCT00591617 is a clinical study titled "Optimizing Outcomes Using Suboxone for Opiate Dependence". Building on a platform of pharmacological treatment with Suboxone (buprenorphine and naloxone), participants are randomly assigned to one of four psychosocial treatment conditions.

What is the current status of trial NCT00591617?

This trial is currently completed. It is a NA study. The enrollment target is 202 participants. The study started on 2006-09. Estimated completion is 2012-12.

What interventions are being tested in trial NCT00591617?

The interventions under investigation include: Psychosocial treatment plus Suboxone pharmacotherapy (OTHER).

Who is sponsoring clinical trial NCT00591617?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00591617's enrollment target sits among peer trials

202 505th of 2000 higher than 1,495 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05272254 · 202 participants · Phase 2

    Povidone Iodine Efficacy Study

  • NCT05701280 · 202 participants · NA

    Pilot/Pivotal Study of DBS+Rehab After Stroke

  • NCT05932589 · 202 participants

    Neurophysiologic Biomarkers in Rett Syndrome

  • NCT06014931 · 202 participants · NA

    Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00591617, the US trial registry maintained by the National Library of Medicine. NCT00591617 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.